# “NordicCan A/S Develops Innovative Cannabinoid Lozenges”

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/patent-watch-nordiccan-a-s-develops-innovative-cannabinoid-2026-09-27/
> **Published:** 2026-09-28T09:03:58-04:00 | **Last Modified / Clinically Audited:** 2026-10-06T11:51:29-04:00
> **Clinical Summary:** NordicCan A/S has filed a patent application for a cannabinoid lozenge formulation, which may offer enhanced bioavailability and targeted delivery of canna

---

PATENT WATCH
 US20260272956A1
 
 
 
 **Assignee:** NordicCan A/S
 **Inventors:** Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
 **Published:** 2026-09-17
 
 

 
 Invention Summary & Claims
 

NordicCan A/S has filed a patent application for a cannabinoid lozenge formulation, which may offer enhanced bioavailability and targeted delivery of cannabinoids. The claimed invention involves a specific combination of excipients and APIs to create a lozenge that can be easily administered orally. This novel formulation could potentially address issues with traditional [cannabis products](https://cedclinic.com/cbd-gummies-daily-use-evidence-men/).

 

 

## Clinical Perspective & Therapeutic Significance

 

Novel cannabinoid delivery systems offer potential advantages in bioavailability and standardized dosing.

 

## Intellectual Property & Market Landscape

 

This patent application reflects ongoing intellectual property investment by NordicCan A/S.

 
 **Official Source Document:** Review the primary patent disclosure and full claims on [Google Patents (US20260272956A1)](https://patents.google.com/patent/US20260272956A1/en).
 

 
 Dr. Caplan’s Take
 

“”This novel lozenge formulation has the potential to improve cannabinoid bioavailability and targeted delivery, which could lead to enhanced therapeutic efficacy in various conditions.””

 

 

 

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.
 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Cannabis Consultation](https://cedclinic.com/book/)
 
 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).